The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in cash.
Source link
GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments
Date:
More like thisRelated
Keiko Fujimori’s party wins Senate presidency in Peru ahead of presidential inauguration
LIMA, Peru -- The Popular Force party, led by...
'Mini Dust Bowl' could be forming in the US, expert warns. Will El Niño make it worse?
"If the long-term drought is as bad as it...
Sazerac Wants Another Shot at Jack Daniel’s Maker Brown-Forman
The Louisville, Ky., company is appealing to members of...